About Icosavax, Inc. 
Icosavax, Inc.
Pharmaceuticals: Major
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 33 Schemes (28.82%)
Foreign Institutions
Held by 40 Foreign Institutions (8.15%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2023)
Net Profit:
-22 Million
Pharmaceuticals: Major
USD 773 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.98
-41.62%
3.33






